TheraNovex Launches Advanced Consent Builder Platform
Streamlined informed consent creation reduces document preparation time by 70% and ensures regulatory compliance
TheraNovex today announced the launch of its advanced Consent Builder platform, a revolutionary tool designed to streamline the creation of informed consent documents for clinical trials. This platform automatically generates compliant consent forms based on study parameters, ensuring regulatory compliance while reducing preparation time by 70%.
Key Platform Features
- Automated generation of compliant consent forms
- Reduces document preparation time by 70%
- Real-time compliance tracking and reporting
- Ensures adherence to regulatory standards
Efficiency Improvements
Revolutionizing Consent Document Creation
Traditional methods of creating informed consent documents often involve manual drafting, extensive legal reviews, and time-consuming revisions. The TheraNovex Consent Builder transforms this process by automating the generation of compliant consent forms based on study-specific parameters.
"Creating informed consent documents has always been a bottleneck in clinical trial preparation," said Dr. Emily Carter, Chief Medical Officer at TheraNovex. "Our Consent Builder not only dramatically reduces the time to create these documents but also ensures that they meet the highest standards of regulatory compliance."
How the Consent Builder Works
The TheraNovex Consent Builder leverages advanced algorithms to:
- Automatically generate consent forms based on study parameters
- Ensure compliance with regulatory requirements
- Provide version control and audit trails
- Support electronic signatures
- Offer multi-language support
"The Consent Builder has transformed our document preparation process. We're now able to create compliant consent forms in minutes rather than hours."— Dr. Robert Chen, Principal Investigator, Advanced Clinical Research
Key Benefits
The TheraNovex Consent Builder offers several key benefits:
Advanced Features
Beyond basic consent form generation, the platform provides advanced features such as:
- Version control to track changes and maintain audit trails
- Electronic signature capabilities for remote consent
- Multi-language support to accommodate diverse participant populations
- Customizable templates to meet specific study needs
- Integration with existing clinical trial management systems
Compliance and Security
The Consent Builder is built with strict compliance and security standards. All data is processed in accordance with HIPAA regulations, and the platform maintains comprehensive audit trails for regulatory compliance. The system also includes role-based access controls and encrypted data transmission to ensure data security.
Integration and Implementation
The TheraNovex Consent Builder integrates seamlessly with existing clinical trial management systems and can be customized for specific study requirements. Implementation typically takes 1-2 weeks and includes comprehensive training for research staff, technical support, and ongoing optimization based on usage patterns.
"We're committed to making clinical trials more efficient and compliant," added Sarah Thompson, VP of Product Development at TheraNovex. "The Consent Builder represents a significant advancement in how we approach informed consent document creation."
About TheraNovex
TheraNovex is a leading clinical research technology company dedicated to accelerating medical breakthroughs through innovative patient recruitment and retention solutions. Our comprehensive platform suite includes AI-powered matching algorithms, digital engagement tools, and advanced consent management technology, all designed to make clinical trials more efficient and compliant.
For more information about TheraNovex's Consent Builder, visit www.theranovex.com or contact our partnership team at partnerships@theranovex.com.